ASLAN Pharmaceuticals ASLN reported its Q4 earnings results on Friday, March 25, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
ASLAN Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 9.87% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.